Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : U

Records returned : 23 (on 16 Jul 2025 at 21:07:39).

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Ulipristal acetate

Drug:

Ulipristal acetate

Indication :

Emergency contraception

Status :

Green

Formulations :

Not Specified

Restrictions / Comments:

Important

Prescribe generically.

For use only in patients seeking emergency contraception between 72 and 120 hours after unprotected vaginal intercourse or contraceptive failure.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Ulipristal acetate

Drug:

Ulipristal acetate

Indication :

Uterine fibroids

Status :

Non Formulary

Formulations :

Tablets

Restrictions / Comments:

Important

MHRA advice: risk of serious liver injury

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NFD1

SPC

3. Umeclidinium (Incruse Ellipta)

Drug:

Umeclidinium (Incruse Ellipta)

(LAMA)

Indication :

Chronic Obstructive Pulmonary Disease (COPD)

Status :

Green

Formulations :

Inhaler (dry powder)

Restrictions / Comments:

Important

Combination with LABA recommended in COPD.

Prescribe by BRAND.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

4. Umeclidinium with vilanterol (Anoro Ellipta)

Drug:

Umeclidinium with vilanterol (Anoro Ellipta)

(LAMA LABA)

Indication :

Chronic Obstructive Pulmonary Disease (COPD)

Status :

Green

Formulations :

Inhaler (dry powder)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

SPC

5. Unithiol

Drug:

Unithiol

Indication :

Heavy metal poisoning

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Important

https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Upadacitinib

Drug:

Upadacitinib

Indication :

Atopic dermatitis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Important

MHRA risk JAK inhibitors

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

ICB

NICE

SPC

7. Upadacitinib

Drug:

Upadacitinib

Indication :

Axial spondyloarthritis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

ICB

NICE

SPC

8. Upadacitinib

Drug:

Upadacitinib

Indication :

Inflammatory bowel disease

Status :

Red

Formulations :

Modified release tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

ICB

NICE

SPC

9. Upadacitinib

Drug:

Upadacitinib

Indication :

Psoriatic arthritis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

ICB

NICE

SPC

10. Upadacitinib

Drug:

Upadacitinib

Indication :

Rheumatoid arthritis

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines

ICB

NICE

SPC

11. Urea hydrogen peroxide

Drug:

Urea hydrogen peroxide

Indication :

Earwax removal

Status :

Green

Formulations :

Ear drops

Restrictions / Comments:

Important

5% ear drops. Available to purchase for self care

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Uridine triacetate

Drug:

Uridine triacetate

Indication :

5-Fluorouracil or capecitabine toxicity

Status :

Red

Formulations :

Granules

Restrictions / Comments:

Important

https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

13. Urofollitropin

Drug:

Urofollitropin

Indication :

Infertility

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Urokinase

Drug:

Urokinase

Indication :

IV catheter maintenance

Status :

Red

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Uromune

Drug:

Uromune

Indication :

Urinary Tract Infection - Prophylaxis

Status :

Red

Formulations :

Sublingual spray

Restrictions / Comments:

Important

Specific indications apply at each acute trust

For urology consultants only.

SASH- Indicated for post-menopausal women who have failed all other treatment options including antibiotic prophylaxis. SASH uromune form must be completed before dispensing and patient issued SaSH Uromune PIL.

ASPH- Recurrent urinary tract infection resistant to other treatment modalities

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP